Aytu Biopharma (AYTU) Net Margin Growth (3y) (2017 - 2025)

Aytu Biopharma (AYTU) Net Margin Growth (3y) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,620.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -98.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,358.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,235.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -100.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4,252.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -404.00
10 Aytu Biopharma 1.43 Mn -25.28 Mn 7.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -2,495.00
Mar 31, 2025 22,051.00
Dec 31, 2024 5,070.00
Sep 30, 2024 12,949.00
Jun 30, 2024 7,131.00
Dec 31, 2023 5,841.00
Sep 30, 2023 2,822.00
Jun 30, 2023 4,101.00
Mar 31, 2023 3,371.00
Dec 31, 2022 14,505.00
Sep 30, 2022 33,993.00
Jun 30, 2022 29,230.00
Mar 31, 2022 -3,125.00
Dec 31, 2021 21,069.00
Sep 30, 2021 11,682.00
Jun 30, 2021 41,484.00
Dec 31, 2020 33,580.00
Sep 30, 2020 39,038.00
Jun 30, 2020 75,857.00
Mar 31, 2020 48,754.00